Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of Persistent Chemotherapy-Induced Thrombocytopenia By Ogkologos - March 26, 2026 52 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the RECITE study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Tarlatamab Transdermal Oestradiol Patches Non-inferior to LHRH Agonists Regarding Metastasis-Free Survival in Patients with Locally Advanced Prostate Cancer EMA Recommends Extension of Indications for Selpercatinib MOST POPULAR 10 Ways the Inflation Reduction Act will Impact Cancer Care August 18, 2022 Cancer Patients May Soon Be Able to Get an Entire Course... January 21, 2020 Shannon’s Law Requires NY Insurance Companies to Cover Mammograms for Ages... August 9, 2019 Our 10 top tips to help you talk about cancer April 24, 2023 Load more HOT NEWS Outcomes of Cancer Patients with SARS-CoV-2 Infection in Veneto Hormone Replacement Therapy Not Linked with Increased Dementia Risk, Study Finds Enfortumab Vedotin Approved for Recurrent Bladder Cancer Nivolumab Added to Cisplatin and Radiotherapy Improves DFS in Patients with...
